期刊文献+

七味白术散对脾虚湿困型肥胖症患者糖脂代谢及肠道菌群的影响 被引量:33

Effects of Qiwei Baizhu Powder(七味白术散)on Glucose and Lipid Metabolism and Intestinal Flora in Obesity Patients of Spleen Deficiency and Dampness Disturbing Type
原文传递
导出
摘要 目的评价七味白术散治疗脾虚湿困型肥胖症的临床疗效。方法34例脾虚湿困型肥胖症患者随机分为治疗组(24例)与对照组(10例)。对照组患者给予指导生活方式、控制并规律饮食、适当运动锻炼干预;治疗组患者在对照组治疗基础上给予七味白术散口服,每日1剂。两组疗程均为3个月。比较两组治疗前后中医证候积分、体重指数(BMI)、血脂[包括甘油三酯(TG)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)]、糖代谢指标[包括空腹血糖(FBG)、空腹胰岛素(FINS)、糖化血红蛋白(HbA1c)、胰岛素抵抗指数(HOMA-IR)]以及肠道菌群分布变化。结果治疗组治疗后中医证候积分、BMI、FINS、HOMA-IR、FBG、TG均较治疗前明显降低,HDL明显升高(P<0.05或P<0.01),而对照组治疗前后各指标差异均无统计学意义(P>0.05)。肠道菌群结果显示,在门水平,治疗组治疗前后拟杆菌门增幅高于对照组拟杆菌门增幅(P<0.05),而厚壁菌门、变形杆菌门、放线菌门和梭形杆菌门两组间差异均无统计学意义(P>0.05)。在属水平,治疗组拟杆菌属、普雷沃菌属治疗后较治疗前有明显上升,拟普雷沃菌属较治疗前显著下降(P<0.05)。结论七味白术散可有效调节脾虚湿困型肥胖症患者肠道菌群分布,改善血糖、血脂代谢。 Objective To evaluate the clinical efficacy of Qiwei Baizhu Powder(七味白术散)in the treatment of obesity of spleen deficiency and dampness disturbing.Methods A total of 34 obese patients with spleen deficiency and dampness disturbing were randomly divided into a treatment group(24 cases)and a control group(10 cases).Patients in the control group were given guidance on lifestyle,controlled and regular diet,and appropriate exercise intervention;patients in the treatment group were additionally given Qiwei Baizhu Powder orally,1 dose per day.The course of treatment for both groups was 3 months.The scores of traditional Chinese medicine(TCM)syndromes,body mass index(BMI),blood lipids including triglycerides(TG),low-density lipoprotein(LDL)and high-density lipoprotein(HDL),glucose metabolism indicators including fasting blood glucose(FBG),fasting insulin(FINS),glycosylated hemoglobin A1c(HbA1c),insulin resistance index(HOMA-IR)and changes in the distribution of intestinal flora before and after treatment were compared.Results The scores of TCM syndromes,BMI,FINS,HOMA-IR,FBG,and TG in the treatment group were significantly lower than before treatment,and HDL was significantly increased(P<0.05 or P<0.01).There was no statistical difference in all indicators in the control group before and after treatment(P>0.05).The results of intestinal flora showed that at the phylum level,the increase of Bacteroides in the treatment group after treatment was higher than the that in the control group(P<0.05).There was no statistically significant difference between groups in Bacillus phylum Firmicutes,Proteobacteria,Actinomycetes and Fusiform(P>0.05).At the genus level,the Bacteroides and Prevotella in the treatment group increased significantly after treatment.Prevotella spp.was significantly decreased after treatment(P<0.05).Conclusion Qiwei Baizhu Powder can effectively regulate the distribution of intestinal flora in obese patients with spleen deficiency and dampness disturbing,and can improve blood sugar and blood lipid metabolism.
作者 刘玲 陆西宛 何珂 朱丽华 LIU Ling;LU Xiyuan;HE Ke;ZHU Lihua(Wuxi Hospital of Traditional Chinese Medicine/Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine,Wuxi,214000)
出处 《中医杂志》 CSCD 北大核心 2020年第23期2082-2086,共5页 Journal of Traditional Chinese Medicine
基金 江苏省中医药管理局科技项目(YB2017048)。
关键词 七味白术散 肥胖症 脾虚湿困型 肠道菌群 糖代谢 脂质代谢 Qiwei Baizhu Powder(七味白术散) obsity syndrome of spleen deficiency and dampness disturbing intestinal flora glucose metabolism lipid metabolism
  • 相关文献

参考文献7

二级参考文献42

  • 1张秀明.茯苓药理作用研究概况[J].中药材,2001,24(6):446-449. 被引量:73
  • 2杨波,伍参荣,唐小梅,胡建中,赵武能.七味白术散对人轮状病毒感染乳鼠血清IFN-γ、TNF-α的影响[J].中国中医药信息杂志,2005,12(3):36-37. 被引量:16
  • 3于辉,李春香,宫凌涛,甘庆贤.甘草的药理作用概述[J].现代生物医学进展,2006,6(4):77-79. 被引量:132
  • 4郑彬.降血糖中药的研究进展[J].天津药学,2007,19(1):53-55. 被引量:7
  • 5中国肥胖问题工作组.中国成人超重和肥胖症预防控制指南(试行)2003版.
  • 6Bao Y,Lu J,Wang C,et al.Optimal waist circumference cutoffs for abdominal obesity in Chinese.Atherosclerosis,2008,201:378-384.
  • 7Dong X,Liu Y,YangJ,et al.Efficiency of anthropometric indicators of obesity for identifying cardiovascular risk factors in a Chinese population.Postgrad Med J,2011,87:251-256.
  • 8Xu F,Wang YF,Lu L,et al.Comparison of anthropometric indices of obesity in predicting subsequent risk of hyperglycemia among Chinese men and women in China's Mainland.Asia Pac J Clin Nutr,2010,19:586-593.
  • 9Shi XD,He SM,Tao YC,et al.Prevalence of obesity and associated risk factors in Northeastern China.Diabetes Res Clin Pract,2011,91:389-394.
  • 10Tsigosa C,Hainer V,Basdevant A,et al.Management of obesity in adults:European clinical practice guidelines.Obes Facts,2008,1:106-116.

共引文献7899

同被引文献582

引证文献33

二级引证文献148

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部